Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05431270
Title Dose Escalation/Expansion Study of PT199 (an Anti-CD73 mAb) Administered Alone and in Combination With a PD-1 Inhibitor
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Phanes Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Carolina BioOncology Institute RECRUITING Huntersville North Carolina 28078 United States Details
Sarah Cannon Research Institute University of Oklahoma RECRUITING Oklahoma City Oklahoma 73104 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Tranquility Research RECRUITING Webster Texas 77598 United States Details
NEXT Oncology RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field